ConductScience.org, home

Paper6682017

A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II).

Harrison R and 7 others. Cancer Chemother Pharmacol, 1983. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II). Papers, record 6682017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6682017

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II).
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1983
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2026-10-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harrison RR
2McAuliffe CAC A
3Zaki AA
4Baer JJ
5Sharma HH
6Smith AA
7Jackson HH
8Fox BWB W

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CisplatinMajor topic
Organoplatinum CompoundsMajor topic
Animals
Kidney
Kinetics
Male
Organ Size
Rats
Rats, Inbred Strains
Spleen
Time Factors
Tissue Distribution

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1657475Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum(II).Clin Chem1978https://conductscience.org/library/papers/657475PubMed
27193043Criteria for the selection of second-generation platinum compounds.Br J Cancer1980https://conductscience.org/library/papers/7193043PubMed
36890414
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease.
Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6890414PubMed
44691408The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt.J Nucl Med1973https://conductscience.org/library/papers/4691408PubMed
5466654Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).Cancer Treat Rep1979https://conductscience.org/library/papers/466654PubMed
6872370Analysis for platinum in biological material by flameless atomic absorption spectrometry.Clin Chem1977https://conductscience.org/library/papers/872370PubMed
74623003Synthesis and distribution of a radiolabeled antitumor agent: cis-diamminedichloroplatinum. II.J Nucl Med1972https://conductscience.org/library/papers/4623003PubMed
8856436Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.Cancer1977https://conductscience.org/library/papers/856436PubMed
94823268Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum (II) in man.J Nucl Med1974https://conductscience.org/library/papers/4823268PubMed
104511865Metabolism of platinum ( 14 C)ethylenediamine dichloride in the rat.Biochem Pharmacol1973https://conductscience.org/library/papers/4511865PubMed
11688279Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man.Cancer Treat Rep1978https://conductscience.org/library/papers/688279PubMed
121277140Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.Cancer Res1976https://conductscience.org/library/papers/1277140PubMed
13326117Cis-diamminedichloroplatinum (II). A new anticancer drug.Ann Intern Med1977https://conductscience.org/library/papers/326117PubMed
144515709Clinical and pharmacological studies with cis-diamminedichloroplatinum (II).Cancer Res1973https://conductscience.org/library/papers/4515709PubMed
15872137Modification of the renal toxicity of cis-dichlorodiammineplatinum(II) with furosemide in male F344 rats.Cancer Treat Rep1977https://conductscience.org/library/papers/872137PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
4053273Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4053273PubMed
4040567Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.J Pharmacokinet Biopharm1985https://conductscience.org/library/papers/4040567PubMed
3888431
In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.
Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3888431PubMed
3293838The comparative tissues distribution of platinum and 14C in mice receiving 14C-labelled carboplatin.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3293838PubMed
3044632An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3044632PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6682017

GET https://conductscience.org/api/papers/v1/6682017/authors